相关实验视频
Updated: Jul 7, 2025

08:42
Myo-mechanical Analysis of Isolated Skeletal Muscle
Published on: February 22, 2011
26.9K
抑制骨肌肉的Lands循环改善因身体不活动而引起的虚弱
Justin L Shahtout1,2, Hiroaki Eshima1,3,4, Patrick J Ferrara1,3
1Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA.
Journal of cachexia, sarcopenia and muscle
|December 20, 2023
概括
由于不使用而导致的骨肌肉缩和软弱可以通过减少脂质氧化物 (LOOH) 来缓解. 在小鼠中抑制酶 lysophosphatidylcholine acyltransferase 3 (LPCAT3),防止肌肉损失,并在后肢卸载期间保持肌肉功能.
科学领域:
- 生物化学 生物化学
- 肌肉生理学 肌肉生理学
- 分子生物学分子生物学
背景情况:
- 脂质氧化物 (LOOH) 与与年龄相关的和不使用诱导的骨肌肉缩有关.
- Lysophosphatidylcholine acyltransferase 3 (LPCAT3) 产生含有多不和脂肪酸的脂,这些脂是LOOH传播的基质.
- 抑制Lands循环,涉及LPCAT3,是一种减少LOOH的潜在策略.
研究的目的:
- 调查通过LPCAT3敲击来减少肌肉特异性LOOH是否可以缓解肌肉缩和肌肉衰弱.
- 确定肌肉脂质过氧化在不使用引起的肌肉功能障碍中的作用.
主要方法:
- 用 LPCAT3 (LPCAT3-MKO) 鼠标的骨肌特异性塔莫西芬诱导性淘汰进行了研究.
- 小鼠经历了7天的后肢卸载 (HU) 或假装程序.
- 评估了肌肉质量,力量产生能力和4-氨 (4-HNE) 结合 (LOOH的标记物).
主要成果:
- 后肢卸载增加了肌肉4-HNE,表明LOOH升高.
- 删除LPCAT3扭转了HU引起的4-HNE的增加.
- 与对照组相比,LPCAT3-MKO小鼠的肌肉缩 (soleus和plantaris) 显著减少,肌肉力量保持.
- 在LPCAT3-MKO小鼠中,肌纤维横截面积的减少减弱.
结论:
- 减少骨肌肉脂质氧化物足以恢复肌肉功能,并防止不使用引起的缩和软弱.
- 肌肉脂质过氧化显著促进了小鼠因不使用而引起的肌肉缩和肌肉衰弱的病理生理学.
相关概念视频
Skeletal Muscle Relaxants: Adverse Effects
375
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
375
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Cross-bridge Cycle
117.5K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.5K
Disorders of the Skeletal Muscle
958
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
958
Skeletal Muscle Relaxants: Therapeutic Uses
487
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
487
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K

